Evidence map›Paper›PMID 40035534›Full record

ArticleMicrobiology spectrum2025

The tradeoffs between persistence and mutation rates at sub-inhibitory antibiotic concentrations in

Alysha S Ismail, Brandon A Berryhill, Teresa Gil-Gil, Joshua A Manuel, Andrew P Smith, Fernando Baquero, Bruce R Levin

Abstract read
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Phenotypic Variation inAntibiotics (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Alysha S IsmailDepartment of Biology, Emory University, Atlanta, Georgia, USA.ORCID 0009-0006-3183-769X
Brandon A BerryhillDepartment of Biology, Emory University, Atlanta, Georgia, USA.ORCID 0000-0003-3430-0901
Teresa Gil-GilDepartment of Biology, Emory University, Atlanta, Georgia, USA.ORCID 0000-0003-0136-3965
Joshua A ManuelDepartment of Biology, Emory University, Atlanta, Georgia, USA.ORCID 0000-0001-6689-6549
Andrew P SmithDepartment of Biology, Emory University, Atlanta, Georgia, USA.ORCID 0000-0002-4848-3131
Fernando BaqueroServicio de Microbiología, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria, and Centro de Investigación Médica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.ORCID 0000-0002-7930-3033
Bruce R LevinDepartment of Biology, Emory University, Atlanta, Georgia, USA.ORCID 0000-0003-3600-2780

Funding

Single Cell Analysis Core (Core C)U19AI158080 · NIAID · EMORY UNIVERSITY · PI LEVIN, BRUCE RICHARD · 2021 to 2025
$10.9M
Theoretical and Experimental Studies of the Population and Evolutionary Dynamics of Bacteria and Bacteriophage.R35GM136407 · NIGMS · EMORY UNIVERSITY · PI LEVIN, BRUCE RICHARD · 2020 to 2024
$2.0M
HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) U19 AI 158080HHS | NIH | National Institute of General Medical Sciences (NIGMS) R35 GM 136407MEC | Instituto de Salud Carlos III (ISCIII)NIAID NIH HHS U19 AI158080NIGMS NIH HHS R35 GM136407
6 · The paper itself

Abstract

The rational design of the antibiotic treatment of bacterial infections employs these drugs to reach concentrations that exceed the minimum needed to prevent the replication of the target bacteria. However, within a treated patient, spatial and physiological heterogeneity promotes antibiotic gradients such that the concentration of antibiotics at specific sites is below the minimum needed to inhibit bacterial growth. Here, we investigate the effects of sub-inhibitory antibiotic concentrations on three parameters central to bacterial infection and the success of antibiotic treatment, using IMPORTANCE: Much of the research on antibiotics and antibiotic treatment has focused on drug concentrations sufficient to prevent the growth of bacteria. These concentrations, however, are not always reached everywhere in the body. Here, we look at the effects of exposure to these low concentrations of antibiotics on the common clinically important pathogen

Indexed as

Anti-Bacterial AgentsMutation RateStaphylococcus aureusComputer SimulationDrug Resistance, BacterialHumansMicrobial Sensitivity TestsMutationStaphylococcal InfectionsAnti-Bacterial Agentsantibiotic heteroresistanceantibiotic resistance mutation rateantibioticsbacterial persistenceminimum inhibitory concentrationpharmacodynamicspopulation biologyStaphylococcus aureus

Identifiers

PMID40035534
PMCPMC11960066

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.